Top Markets
Coin of the day
Caliway Biopharmaceuticals Co. L Caliway Biopharmaceuticals Co. L

Caliway Biopharmaceuticals Co. L

6919
Rank in Stocks #3556
Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated... Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated to developing pharmaceuticals primarily in the fields of aesthetic medicine and chronic inflammation. Its lead investigational drug, CBL-514, is currently undergoing Phase 2 clinical trials, targeting non-surgical fat reduction, Dercum's disease, and cellulite. Beyond this, the firm is also progressing CBA-539 through preclinical exploration for potential applications in central obesity, hyperpigmentation, and skin aging. The company's offerings also extend to dietary supplements. Established in 2012, Caliway Biopharmaceuticals operates from its headquarters in New Taipei City, Taiwan.
Share Price
$3.28
Last synced: 2026-07-31
Market Cap
$5.10B
Change (1 day)
0.00%
Change (1 year)
-49.70%
Country
TW
Trade Caliway Biopharmaceuticals Co. L (6919)

Category

Stock split history for Caliway Biopharmaceuticals Co. L (6919)
Caliway Biopharmaceuticals Co. L stock (symbol: 6919) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 26, 2026.
One 6919 share bought prior to Aug 26, 2026 would equal to 0 6919 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH